NRG Energy Inc vs Regeneron Pharmaceuticals Inc — how do they compare? NRG Energy Inc trades at $132.3 (market cap $27.55B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.6× NRG Energy Inc's market cap, and NRG Energy Inc pays the higher dividend (1.46%). Which is the better fit depends on your goals.
| NRG | REGN | |
|---|---|---|
Market Cap | $27.55B | $70.47B |
Sector | Utilities | Health |
52-Week High | $184.03 | $812.27 |
52-Week Low | $120.65 | $545.46 |
Enterprise Value | $51.38B | $64.42B |
Dividend Yield | 1.46% | 0.56% |
Trailing returns across standard periods
Latest headlines on both assets
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →